Prognostic value of brain natriuretic peptide in the management of patients receiving cardiac resynchronization therapy

European Journal of Heart Failure

Volumn 8, Issue 5, 2006, Pages 509-514

  Pitzalis, Maria Vittoria ^a   Iacoviello, Massimo ^b   Di Serio, Francesca ^c   Romito, Roberta ^d   Guida, Pietro ^b   De Tommasi, Elisabetta ^b   Luzzi, Giovanni ^b   Anaclerio, Matteo ^b   Varraso, Lucia ^c   Forleo, Cinzia ^b   Pansini, Nicola ^c  

^a EAST CAROLINA UNIVERSITY   (United States)

^b UNIVERSITY OF BARI   (Italy)

^c POLICLINICO   (Italy)

^d IRCCS   (Italy)

Author keywords

Brain natriuretic peptide; Cardiac resynchronization therapy; Echocardiography; Heart failure; Ventricular remodelling

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

ADULT; AGED; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; CHEMOLUMINESCENCE; DISEASE COURSE; FEMALE; FOLLOW UP; HEART BUNDLE BRANCH BLOCK; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART VENTRICLE REMODELING; HOSPITAL PATIENT; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; SENSITIVITY AND SPECIFICITY; TIME SERIES ANALYSIS;

AGED; CARDIAC PACING, ARTIFICIAL; DISEASE PROGRESSION; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; HEART FAILURE; HEART FAILURE, CONGESTIVE; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PACEMAKER, ARTIFICIAL; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RISK ASSESSMENT; SURVIVAL ANALYSIS; VENTRICULAR REMODELING;

EID: 33747021419     PISSN: 13889842     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejheart.2005.10.013     Document Type: Article

References (21)

1. Jessup M., and Brozena S. Heart failure. N Engl J Med 348 (2003) 2007-2018
2. Khand A., Gemmel I., Clark A.L., and Cleland J.G. Is the prognosis of heart failure improving?. J Am Coll Cardiol 36 (2000) 2284-2286
3. Cazeau S., Leclercq C., Lavergne T., Walker S., Varma C., Linde C., et al. Multisite Stimulation in Cardiomyopathies (MUSTIC) Study Investigators. Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. N Engl J Med 344 (2001) 873-880
4. Abraham W.T., Fisher W.G., Smith A.L., Delurgio D.B., Leon A.R., Loh E., et al., MIRACLE Study Group. Multicenter InSync Randomized Clinical Evaluation. Cardiac resynchronization in chronic heart failure. N Engl J Med 346 (2002) 1845-1853
5. Bristow M.R., Saxon L.A., Boehmer J., Krueger S., Kass D.A., De Marco T., et al. Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Investigators. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 350 (2004) 2140-2150
6. Cleland J.G., Daubert J.C., Erdmann E., Freemantle N., Gras D., Kappenberger L., et al. Cardiac Resynchronization-Heart Failure (CARE-HF) Study Investigators. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 352 (2005) 1539-1549
7. Reuter S., Garrigue S., Barold S.S., Jais P., Hocini M., Haissaguerre M., et al. Comparison of characteristics in responders versus nonresponders with biventricular pacing for drug-resistant congestive heart failure. Am J Cardiol 89 (2002) 346-350
8. Pitzalis M.V., Iacoviello M., Romito R., Massari F., Rizzon B., Luzzi G., et al. Cardiac resynchronization therapy tailored by echocardiographic evaluation of ventricular asynchrony. J Am Coll Cardiol 40 (2002) 1615-1622
9. Pitzalis M.V., Iacoviello M., Romito R., Guida P., De Tommasi E., Luzzi G., et al. Ventricular asynchrony predicts a better outcome in patients with chronic heart failure receiving cardiac resynchronization therapy. J Am Coll Cardiol 45 (2005) 65-69
10. Sogaard P., Egeblad H., Kim W.Y., Jensen H.K., Pedersen A.K., Kristensen B.O., et al. Tissue Doppler imaging predicts improved systolic performance and reversed left ventricular remodeling during long-term cardiac resynchronization therapy. J Am Coll Cardiol 40 (2002) 723-730
11. Yu C.M., Fung W.H., Lin H., Zhang Q., Sanderson J.E., and Lau C.P. Predictors of left ventricular reverse remodeling after cardiac resynchronization therapy for heart failure secondary to idiopathic dilated or ischemic cardiomyopathy. Am J Cardiol 91 (2003) 684-688
12. Levin E.R., Gardner D.G., and Samson W.K. Natriuretic peptides. N Engl J Med 339 5 (1998) 321-328
13. Stanek B., Frey B., Hulsmann M., Berger R., Sturm B., Strametz-Juranek J., et al. Prognostic evaluation of neurohumoral plasma levels before and during beta-blocker therapy in advanced left ventricular dysfunction. J Am Coll Cardiol 38 (2001) 436-442
14. Tsutamoto T., Wada A., Maeda K., Hisanaga T., Maeda Y., Fukai D., et al. Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure: prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction. Circulation 96 (1997) 509-516
15. Troughton R.W., Frampton C.M., Yandle T.G., Espiner E.A., Nicholls M.G., and Richards A.M. Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations. Lancet 355 (2000) 1126-1130
16. Colucci W.S., Packer M., Bristow M.R., Gilbert E.M., Cohn J.N., Fowler M.B., et al. Carvedilol inhibits clinical progression in patients with mild symptoms of heart failure. US Carvedilol Heart Failure Study Group. Circulation 94 (1996) 2800-2806
17. Pitt B., Remme W., Zannad F., Neaton J., Martinez F., Roniker B., et al. Eplerenone post-acute myocardial infarction heart failure efficacy survival study investigators. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 348 (2003) 1309-1321
18. St John Sutton M.G., Plappert T., Abraham W.T., Smith A.L., DeLurgio D.B., Leon A.R., et al. Multicenter InSync Randomized Clinical Evaluation (MIRACLE) Study Group. Effect of cardiac resynchronization therapy on left ventricular size and function in chronic heart failure. Circulation 107 (2003) 1985-1990
19. McDonagh T.A., Robb S.D., Murdoch D.R., Morton J.J., Ford I., Morrison C.E., et al. Biochemical detection of left-ventricular systolic dysfunction. Lancet 351 (1998) 9-13
20. Kinnunen P., Vuolteenaho O., and Ruskoaho H. Mechanisms of atrial and brain natriuretic peptide release from rat ventricular myocardium: effect of stretching. Endocrinology 132 (1993) 1961-1970
21. Sinha A.M., Filzmaier K., Breithardt O.A., Kunz D., Graf J., Markus K.U., et al. Usefulness of brain natriuretic peptide release as a surrogate marker of the efficacy of long-term cardiac resynchronization therapy in patients with heart failure. Am J Cardiol 91 (2003) 755-758